Sam Chun Dang Pharm Co Ltd (000250)

KOSDAQ
Currency in KRW
130,900
-8,400(-6.03%)
Closed·
000250 Scorecard
Full Analysis
Stock has taken a big hit over the last week
000250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
127,600139,300
52 wk Range
88,200230,000
Key Statistics
Edit
Bid/Ask
130,900.00 / 131,000.00
Prev. Close
130,900
Open
138,500
Day's Range
127,600-139,300
52 wk Range
88,200-230,000
Volume
400.37K
Average Volume (3m)
285.58K
1-Year Change
17.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
No news in this category
Looks like there are no results in this news category

Sam Chun Dang Pharm Company Profile

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, South Korea.

Employees
409

Compare 000250 to Peers and Sector

Metrics to compare
000250
Peers
Sector
Relationship
P/E Ratio
−278.9x9.9x−0.5x
PEG Ratio
-0.030.00
Price/Book
11.4x0.9x2.6x
Price / LTM Sales
14.4x0.7x3.0x
Upside (Analyst Target)
-49.7%54.7%
Fair Value Upside
Unlock32.1%8.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -474.29%
Dividend Yield
0.14%
Industry Median 0.26%
Annualised payout
200.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 19, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Sam Chun Dang Pharm (000250) Stock Price Today?

The Sam Chun Dang Pharm stock price today is 130,900.00.

What Stock Exchange Does Sam Chun Dang Pharm Trade On?

Sam Chun Dang Pharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Sam Chun Dang Pharm?

The stock symbol for Sam Chun Dang Pharm is "000250."

Does Sam Chun Dang Pharm Pay Dividends? What’s The Current Dividend Yield?

The Sam Chun Dang Pharm dividend yield is 0.15%.

What Is the Sam Chun Dang Pharm Market Cap?

As of today, Sam Chun Dang Pharm market cap is 3.04T.

What Is Sam Chun Dang Pharm's Earnings Per Share (TTM)?

The Sam Chun Dang Pharm EPS (TTM) is -474.29.

When Is the Next Sam Chun Dang Pharm Earnings Date?

Sam Chun Dang Pharm will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is 000250 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.